Condensed Consolidated Statements Of Cash Flows	6 Months Ended
	Aug. 28, 2020 USD ($)		Aug. 23, 2019 USD ($)
OPERATING ACTIVITIES
Net income	$ 17,400,000		$ 78,300,000
Depreciation and amortization	43,300,000		41,400,000
Goodwill, Impairment Loss	17,600,000		0
Restructuring Charges	15,600,000		0
Increase (Decrease) in Deferred Income Taxes	18,000,000.0		2,900,000
Non-cash stock compensation	9,700,000		12,000,000.0
Equity in income of unconsolidated affiliates	(3,900,000)		(5,700,000)
Dividends received from unconsolidated affiliates	2,800,000		8,200,000
Other	(12,500,000)		(800,000)
Changes in operating assets and liabilities net of acquisitions:
Accounts receivable	58,000,000.0		(82,200,000)
Inventories	(200,000)		(20,500,000)
Other assets	(10,800,000)		3,900,000
Accounts payable	(36,500,000)		37,800,000
Employee compensation liabilities	(120,800,000)		(46,100,000)
Employee benefit obligations	(24,900,000)		(17,700,000)
Increase (Decrease) in Customer Advances and Deposits	74,300,000		7,400,000
Accrued Liabilities and Other Operating Liabilities	(2,200,000)		23,900,000
Net cash provided by operating activities	44,900,000		42,800,000
INVESTING ACTIVITIES
Capital expenditures	(18,000,000.0)		(32,500,000)
Proceeds from Sale of Property, Plant, and Equipment	7,100,000		1,000,000.0
Other	4,900,000		1,900,000
Net cash provided by (used in) investing activities	(6,000,000.0)		(29,600,000)
FINANCING ACTIVITIES
Dividends paid	(20,100,000)		(34,500,000)
Common stock repurchases	(42,300,000)		(5,900,000)
Proceeds from Lines of Credit	250,000,000.0		0
Repayments of Lines of Credit	(250,000,000.0)		0
Proceeds from (Payments for) Other Financing Activities	(1,400,000)		(2,300,000)
Net cash used in financing activities	(63,800,000)		(42,700,000)
Effect of exchange rate changes on cash and cash equivalents	200,000		(1,400,000)
Net decrease in cash, cash equivalents and restricted cash	(24,700,000)		(30,900,000)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	547,100,000	[1]	264,800,000	[1]
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 522,400,000	[2]	233,900,000	[2]
Restricted Cash			$ 4,800,000

[1] These amounts include restricted cash of $6.1 and $3.5 as of February 28, 2020 and February 22, 2019, respectively.

[2] These amounts include restricted cash of $6.5 and $4.8 as of August 28, 2020 and August 23, 2019, respectively.Restricted cash primarily represents funds held in escrow for potential future workers’ compensation and product liability claims.  Restricted cash is included as part of Other assets in the Condensed Consolidated Balance Sheets.